Fluvoxamine Maleate in the Treatment of Obsessive-Compulsive Disorder: A Post-marketing Clinical Study in Children and Adolescents
NCT ID: NCT00352768
Last Updated: 2010-03-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
PHASE4
20 participants
INTERVENTIONAL
2006-08-31
2009-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Phase 3 Study of Fluvoxamine (SME3110) in Pediatric/Adolescent Patients With Obsessive Compulsive Disorder
NCT01933919
Treatment for Anxiety in Children
NCT00000389
Developing Adaptive Treatment Strategies for Children and Adolescents With Obsessive-compulsive Disorder.
NCT01148316
Study of NPL-2003 in Adolescents With Obsessive Compulsive Disorder (OCD)
NCT00515255
Fluoxetine vs CBT in Childhood Anxiety Disorders
NCT04760275
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
F
Fluvoxamine maleate
Test product: Fluvoxamine maleate 25mg tablet. In case that the daily dose is one tablet, the study medication will orally be administered once daily, at bedtime. In case that the daily dose is two tablets or higher (maximam:6 tablets), the study mmedica
P
Placebo
Placebo
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Fluvoxamine maleate
Test product: Fluvoxamine maleate 25mg tablet. In case that the daily dose is one tablet, the study medication will orally be administered once daily, at bedtime. In case that the daily dose is two tablets or higher (maximam:6 tablets), the study mmedica
Placebo
Placebo
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
8 Years
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Solvay Pharmaceuticals
INDUSTRY
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Toshiaki Yamaguchi
Role: STUDY_DIRECTOR
Solvay Pharmaceuticals
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
S114.3.118 Kohnodai Hospital, National Center of N
Chiba Prefecture, , Japan
S114.3.118 Kyushu University Hospital
Fukuoka Prefecture, , Japan
S114.3.118 Hiroshima-city Funairi Hospital
Hiroshima Prefecture, , Japan
S114.3.118 Goryokai Hospital
Hokkaido Prefecture, , Japan
S114.3.118 Hyogo Children's Hospital
Hyogo Prefecture, , Japan
S114.3.118 Kobe University Hospital
Hyogo Prefecture, , Japan
S114.3.118 National Hospital Organization Kagawa C
Kagawa Prefecture, , Japan
S114.3.118 National Hospital Organization Kikuti N
Kumamoto Prefecture, , Japan
S114.3.118 National Hospital Organization Sakakiba
Mie Prefecuture, , Japan
S114.3.118 Nara Medical University Hospital
Nara Prefecture, , Japan
S114.3.118 Tokushima University Hospital
Tokushima Prefecture, , Japan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
S114.3.118
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.